Methadone in primary care in France: Using evidence for action against hepatitis C - Aix-Marseille Université Access content directly
Journal Articles International Journal of Drug Policy Year : 2019

Methadone in primary care in France: Using evidence for action against hepatitis C

Abstract

In France, two opioid substitution treatments have been available since the mid-1990s: buprenorphine through primary care and specialized clinics, and methadone only through specialized clinics.
Fichier principal
Vignette du fichier
S0955395919301689.pdf (145.71 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02613452 , version 1 (25-10-2021)

Licence

Attribution - NonCommercial

Identifiers

Cite

P. Roux, A. Morel, D. Wolfe, Patrizia M. Carrieri. Methadone in primary care in France: Using evidence for action against hepatitis C. International Journal of Drug Policy, 2019, 71, pp.91-92. ⟨10.1016/j.drugpo.2019.06.013⟩. ⟨hal-02613452⟩
42 View
81 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More